secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001654954-25-005749
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica Q1 revenue $6.5M (+4% YoY), net loss $63.8M on $55.8M impairment
-------------------------------------------------------------------------

- Revenue $6.5M (+4% YoY); gross margin 68% vs 66% in Q1 2024.
- Net loss $63.8M includes $55.8M non-cash impairment from share price decline.
- Adjusted EBITDA loss $5.7M vs $5.3M in Q1 2024; cash & securities $64.6M.
- Consumables revenue up 13% to $4.5M; Diagnostics down 25% to $0.6M.
- Shares outstanding 979.9M; liquidity down from $71.4M at Dec 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495425005749/0001654954-25-005749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495425005749/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-005749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer